Sen, Sukanta. 2013. “Canagliflozin (Invokana®): A First-in-Class Anti-Diabetic Drug”. Journal of Drug Delivery and Therapeutics 3 (3), 145-46. https://doi.org/10.22270/jddt.v3i3.490.